Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Outcomes of Multiple Myeloma Patients Relapsing After Upfront Autologous Stem Cell Transplant in a Brazilian Public Center: Real-World Data
Marcelo Junqueira Atanazio (he/him/his)
Assistant physician
Instituto do Cancer do Estado de Sao Paulo
São Paulo, Sao Paulo, Brazil